The seasonal influenza A has entered the epidemic period, and the sales of related Chinese Patent Medicine products have significantly increased.

① Recently, the positive rate of influenza virus has significantly increased, with over 99% being type A influenza. Market data shows a clear increase in the demand for various Traditional Chinese Medicine cold medicine products. ② Today, stock prices of several listed companies in the Traditional Chinese Medicine Industry, such as Shanxi Zhendong Pharmaceutical, Hainan Huluwa Pharmaceutical Group, and Zhongsheng Pharmaceutical, have reached the daily limit, with the Traditional Chinese Medicine Sector overall rising, and the Traditional Chinese Medicine 50 ETF increasing by 3.21%.

cls.cnJan 6 21:42

GuangYuYuan Chinese Herbal Medicine (600771): State-owned Enterprise Reform begins to show results as property rights relationships are further streamlined.

Event: 1) According to the company's announcement, on December 19, 2024, Hainan Shennong Technology Group signed a "Share Transfer Agreement" with Venture Capital, whereby Hainan Shennong Technology Group acquires 71,508,9 shares held by Venture Capital in GuangYuYuan Chinese Herbal Medicine.

China Great WallDec 24, 2024 00:00

GuangYuYuan Chinese Herbal Medicine (600771.SH): The largest Shareholder is proposed to change from Venture Capital to Hainan Shennong Technology Group.

On December 19, Gelonghui reported that GuangYuYuan Chinese Herbal Medicine (600771.SH) announced that its controlling shareholder, Hainan Shennong Technology Group Co., Ltd. (referred to as "Hainan Shennong Technology Group"), has signed a "Share Transfer Agreement between JinChuang Investment Co., Ltd. and Hainan Shennong Technology Group Co., Ltd. regarding GuangYuYuan Chinese Herbal Medicine Co., Ltd." JinChuang Investment intends to transfer its 71,508,968 shares in the company, accounting for 14.61% of the total share capital, to Hainan Shennong Technology Group through a non-public agreement, while also terminating the previous delegation of 14.6% of shares that JinChuang Investment entrusted Hainan Shennong Technology Group to exercise.

Gelonghui FinanceDec 19, 2024 17:09

Guangyuyuan Traditional Chinese Medicine Co., Ltd. Report for the third quarter of 2024

SZSIOct 26, 2024 00:00 · Announcements

Guangyuyuan Chinese Herbal Medicine (600771.SH): The net income for the first three quarters was 70.9642 million yuan, a year-on-year decrease of 22.49%.

Guangyuyuan (600771.SH) announced its third quarter report for 2024 on October 25th, with the company's revenue for the first three quarters of the year at 0.894 billion yuan, a decrease of 7.93% year-on-year; net income attributable to shareholders of the listed company was 70.9642 million yuan, a decrease of 22.49% year-on-year; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 65.334 million yuan, a decrease of 18.13% year-on-year; basic earnings per share was 0.14 yuan.

Gelonghui FinanceOct 25, 2024 17:07

Express News | Guangyuyuan Chinese herbal medicine: net income of 70.9642 million yuan in the first three quarters, a year-on-year decrease of 22.49%.

BreakingsOct 25, 2024 17:03